Fingerprint
Dive into the research topics where Lara Davis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Activity of pemetrexed in recurrent, metastatic sacral chordoma: A case report
Celestino, D. G., Davis, L. E. & Kesari, S., Mar 1 2025, In: Current Problems in Cancer: Case Reports. 17, 100340.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Choe, M., Kirkey, D., Lira, I., Hawkins, G., Blankenfeld, M., Menashe, S., Ries, R. E., Wrightson, B., Root, C., McKay, C. N., Peplinski, J. H., Glabman, R., Davis, L. E., Malhotra, S. V., Gorlick, R., Loggers, E. T. & Meshinchi, S., Jan 1 2025, In: Cancer Research Communications. 5, 9, p. 1701-1713 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Ribociclib in Sequential Combination with Doxorubicin in Anthracycline-Naïve Advanced Soft-Tissue Sarcomas: Results of a Dose-Finding Phase Ib Study
Davis, L. E., Zhu, L., Latour, E., McMahon, N., Nishikawa, G., Choo, F., Nusser, K. D., Pittsenbarger, J., Burch, R., Park, B., Mills, G. B., Davis, J. L., Davare, M. & Ryan, C. W., Jan 1 2025, In: Clinical Cancer Research. 31, 13, p. 2599-2607 9 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
Mowery, Y. M., Ballman, K. V., Hong, A. M., Schuetze, S. M., Wagner, A. J., Monga, V., Heise, R. S., Attia, S., Choy, E., Burgess, M. A., Bae, S., Pryor, D. I., Van Tine, B. A., Tinoco, G., Chmielowski, B., Freeman, C., Gronchi, A., Meyer, C. F., Dickson, M. A. & Hartner, L. & 8 others, , Nov 23 2024, In: The Lancet. 404, 10467, p. 2053-2064 12 p.Research output: Contribution to journal › Article › peer-review
Open Access50 Link opens in a new tab Scopus citations -
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma
Meyers, P. A., Federman, N., Daw, N., Anderson, P. M., Davis, L. E., Kim, A. R., Macy, M. E., Pietrofeso, A., Ratan, R., Riedel, R. F., Trucco, M., Breitmeyer, J. B., Toretsky, J. A. & Ludwig, J. A., Nov 1 2024, In: Journal of Clinical Oncology. 42, 31, p. 3725-3734 10 p.Research output: Contribution to journal › Article › peer-review
Open Access25 Link opens in a new tab Scopus citations